• HOME

    • Discussion Group
  • ABOUT

  • SOLUTIONS

    • OGP Technology
    • Optimal Launch Pricing
    • Parallel Trade
  • CONTACT

  • Forum

  • Members

  • Blog

  • More

    Use tab to navigate through the menu items.
    DNA representing medical sciences
    iEDC - intelligent Electronic Data Capture

    We think global

    OGT is the company logo
    Geometric Programming fundamental research applied to Medicines markets
    To see this working, head to your live site.
    • Categories
    • All Posts
    • My Posts

    OGP - Opt Global Pricing

    Explore your forum below to see what you can do, or head to Settings to start managing your Categories.

    Parallel Trade

    Preview your site to navigate your forum. This is where you go to add, edit & delete posts and comments.
    Views 
    Posts6

    Optimal Launch Pricing

    Add and delete posts & comments on the go. Simply Publish your site, then sign in with your Wix account on your mobile.
    Views 
    Posts4

    Discover Awesome Features

    Stunning layouts, unlimited discussions & real time messaging - it’s all right here!
    Views 
    Posts3

    Stand Out From the Crowd

    Want to make your posts stand out? You can add images, text styles and more - it’s easy!
    Views 
    Posts3

    Resolving the Med. Crises

    Resolving the medicines crises with OCP (Optimal Commercial Policies) based on optimal solutions.
    Views 
    Posts1
    New Posts
    • scurtum
      Jun 10, 2017
      Global launch of medicines
      Optimal Launch Pricing
      Current practice of launching sequentially new drugs on the global market is forgoing the pharma business hundreds of millions of dollars. OGP - Optimal Global Pricing technology is solving this problems. OGP enables a pricing function which is paralleling the drug development process. When the drug is ready to be launched the regulatory agencies have already seen/approved global pricing structure all along and the price negotiations with individual markets are cut short.
      0 comments0
      1